|

SEP-363856 Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since September 2026

Also known as: Ulotaront

Pipeline

Phase 3: 3

Top Sponsors

  • Otsuka Pharmaceutical Development & Commercialization, Inc.3

Indications

  • Generalized Anxiety Disorder3
  • Anxiety3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.